Actively Recruiting
A Study Of MCG In Cardiac Amyloidosis
Led by Mayo Clinic · Updated on 2025-12-22
500
Participants Needed
1
Research Sites
99 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective of this observational study is to evaluate the utility of magnetocardiography (MCG) in diagnosing and monitoring disease progression in patients with amyloidosis, and to assess its effectiveness in comparison to other modalities, such as ECG.
CONDITIONS
Official Title
A Study Of MCG In Cardiac Amyloidosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older at the time of consent
- Ability to follow study requirements
- Able and willing to provide written informed consent
You will not qualify if you...
- Pregnant or breastfeeding
- Having an active atrial fibrillation episode on the latest 12-lead ECG
- Presence of active thoracic metal implants such as pacemaker, insertable cardiac monitor, or internal defibrillator
- Use of external electrical pads or devices that must remain on the chest during the MCG scan
- Unable to lie down in a supine or inclined position and remain still during the examination
- Any clinical condition that the investigator believes would risk patient safety or interfere with study completion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
A
Andy Dang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here